Literature DB >> 4209358

Role of meningococcal endotoxin in meningococcal purpura.

C E Davis, K Arnold.   

Abstract

Enteric bacilli and meningococci (MGC) both contain potent endotoxins, but purpuric skin lesions indistinguishable from the experimental dermal Shwartzman reaction are much more common during meningococcal bacteremia than during bacteremia with enteric organisms. Highly purified lipopolysaccharides (LPS), virtually free of contamination by protein, RNA, and capsule, were extracted by a modification of the phenol-water technique from MGC (serogroups A, B, and C) and enteric bacilli (Escherichia coli 04 and 0:111, and Salmonella typhimurium). Polysaccharides in these LPS were similar by gas chromatography except for one galactose-deficient strain of MGC (135B). LPS from MGC and enterics were equally potent for the general Shwartzman reaction and mouse lethality, but LPS from MGC was 5-10 times more potent in inducing the dermal Shwartzman reaction. The greater skin potency of LPS from MGC explains the prominence of purpura in meningococcemia. Comparison of the properties of LPS may explain other differences in clinical syndromes caused by gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4209358      PMCID: PMC2139705          DOI: 10.1084/jem.140.1.159

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

Review 1.  BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. II. SPECIAL NEUROLOGIC PROBLEMS, POSTMENINGITIC COMPLACATIONS AND CLINICOPATHOLOGICAL CORRELATIONS.

Authors:  P R DODGE; M N SWARTZ
Journal:  N Engl J Med       Date:  1965-05-06       Impact factor: 91.245

2.  Studies with radioactive endotoxin. I. The use of Cr51 to label endotoxin of Escherichia coli.

Authors:  A I BRAUDE; F J CAREY; D SUTHERLAND; M ZALESKY
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

3.  Treatment and prevention of intravascular coagulation with antiserum to endotoxin.

Authors:  A I Braude; H Douglas; C E Davis
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis.

Authors:  T A Hoffman; E A Edwards
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

5.  Distribution of keto-deoxyoctonic acid and sialic acid in N. meningitidis.

Authors:  E Hackenthal
Journal:  J Immunol       Date:  1969-04       Impact factor: 5.422

Review 6.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.

Authors:  O Lüderitz; A M Staub; O Westphal
Journal:  Bacteriol Rev       Date:  1966-03

7.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

8.  Studies on human platelet gangliosides.

Authors:  A J Marcus; H L Ullman; L B Safier
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Galactose-deficient endotoxin from urinary Escherichia coli.

Authors:  J L Ryan; A I Braude; M Turck
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  16 in total

1.  Meningococcus.

Authors:  E Slater
Journal:  West J Med       Date:  1977-10

2.  Comparison of lipopolysaccharides from Brazilian purpuric fever isolates and conjunctivitis isolates of Haemophilus influenzae biogroup aegyptius. Brazilian Purpuric Fever Study Group.

Authors:  A L Erwin; R S Munford
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

Review 3.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

4.  Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions.

Authors:  M van Deuren; B J van Dijke; R J Koopman; A M Horrevorts; J F Meis; F W Santman; J W van der Meer
Journal:  BMJ       Date:  1993-05-08

5.  Magnitude of bacteremia and complement activation during Neisseria meningitidis infection: study of two co-primary cases with different clinical presentations.

Authors:  A Zwahlen; F A Waldvogel
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

6.  Ability of gonococcal and meningococcal lipooligosaccharides to clot Limulus amebocyte lysate.

Authors:  R I Roth; R Yamasaki; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Lipopolysaccharide serotyping of Neisseria meningitidis by hemagglutination inhibition.

Authors:  R E Mandrell; W D Zollinger
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

8.  A case of disseminated intravascular coagulation caused by Brucella melitensis.

Authors:  Tuba Turunc; Yusuf Ziya Demiroglu; Ebru Kizilkilic; Hikmet Aliskan; Can Boga; Hande Arslan
Journal:  J Thromb Thrombolysis       Date:  2007-06-12       Impact factor: 2.300

9.  Adhesion of Neisseria meningitidis to dermal vessels leads to local vascular damage and purpura in a humanized mouse model.

Authors:  Keira Melican; Paula Michea Veloso; Tiffany Martin; Patrick Bruneval; Guillaume Duménil
Journal:  PLoS Pathog       Date:  2013-01-24       Impact factor: 6.823

10.  Neutralization of meningococcal endotoxin by antibody to core glycolipid.

Authors:  C E Davis; E J Ziegler; K F Arnold
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.